ArticleSignal transduction and targeted therapy2023

Safety and clinical efficacy of sintilimab (anti-PD-1) in pediatric patients with advanced or recurrent malignancies in a phase I study.

Yi Que et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.